Rapidly Progressive Disseminated Bacillus Calmette-Guérin Infection (BCGitis) in a 3-Month-Old Infant Without Immunodeficiency: A Case Report
View abstract on PubMed
Summary
This summary is machine-generated.Disseminated Bacillus Calmette-Guerin (BCG) disease is a rare, fatal complication of BCG vaccination. Early recognition and a 7-month antibiotic regimen led to successful treatment in a previously healthy infant.
Area Of Science
- Pediatrics
- Infectious Diseases
- Vaccinology
Background
- Disseminated Bacillus Calmette-Guerin (BCG) disease is a severe, rare complication of BCG vaccination with high mortality.
- It predominantly affects immunocompromised children, with incidence rates of 1.56-4.29 per million vaccinated individuals.
- Typical lesions appear near the injection site, but rare presentations can occur.
Purpose Of The Study
- To report a rare case of disseminated BCGitis with unusual head and neck involvement.
- To highlight the diagnostic challenges and successful treatment of this severe complication.
- To emphasize the importance of early recognition for improved patient outcomes.
Main Methods
- Case report of a 3-month-old infant with disseminated BCGitis.
- Clinical presentation, diagnostic investigations, and treatment regimen described.
- Long-term follow-up to assess sequelae and neurodevelopment.
Main Results
- The infant presented with extensive skin, subcutaneous, bone, lymphatic, and systemic complications in the head and neck.
- The lesions mimicked malignant neoplasm due to rapid, destructive growth.
- Successful treatment with a 7-month course of rifampicin, isoniazid, and ethambutol resulted in complete resolution without sequelae.
Conclusions
- Disseminated BCGitis can manifest sporadically or as a sign of primary/secondary immunodeficiency.
- Rapid progression and high fatality underscore the critical need for prompt diagnosis and intervention.
- The case demonstrates that even severe presentations can be successfully managed with appropriate antimicrobial therapy.

